Literature DB >> 26822307

Missing link between microRNA and prostate cancer.

Balraj Singh Gill1, Jimi Marin Alex2, Sanjeev Kumar3.   

Abstract

MicroRNAs are the non-coding RNAs which regulate endogenous gene expression in animal and plant cells. Alterations in the level of micro-ribonucleic acids (miRNAs) involving the deletions, overexpression, mutations, epigenetic silencing, or dysregulation of transcription factors that target specific miRNAs may culminate in various diseases including cancer. Recent findings demonstrate the role of miRNAs in prostate cancer. Numerous discoveries of miRNAs have marked the research and development surrounding prostate cancer management, diagnosis, and therapy which has made prediction easy, but the effective treatment strategy remains a mystery. This review seeks to draw a link between miRNA and prostate cancer through an understanding of the numerous signaling pathways that these miRNAs control, which may prove to be helpful in identifying therapeutically interesting molecular targets.

Entities:  

Keywords:  Apoptosis; Biomarker; Prostate cancer (PCa); Signaling; miRNA

Mesh:

Substances:

Year:  2016        PMID: 26822307     DOI: 10.1007/s13277-016-4900-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  185 in total

1.  Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles.

Authors:  Yang Pan; Yuan Zhang; Tingting Jia; Kuo Zhang; Jinming Li; Lunan Wang
Journal:  FEBS J       Date:  2012-02-23       Impact factor: 5.542

2.  MicroRNA-146a modulates TGF-β1-induced phenotypic differentiation in human dermal fibroblasts by targeting SMAD4.

Authors:  Zhen Liu; Cui-Ling Lu; Li-Ping Cui; Yong-Liang Hu; Qi Yu; Ying Jiang; Tian Ma; Da-Kai Jiao; Di Wang; Chi-Yu Jia
Journal:  Arch Dermatol Res       Date:  2011-10-04       Impact factor: 3.017

3.  Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authors:  Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan Yu; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

4.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

Authors:  Yiwei Li; Timothy G VandenBoom; Dejuan Kong; Zhiwei Wang; Shadan Ali; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

5.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Authors:  Minoru Toyota; Hiromu Suzuki; Yasushi Sasaki; Reo Maruyama; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

6.  Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.

Authors:  Heidi J Peltier; Gary J Latham
Journal:  RNA       Date:  2008-03-28       Impact factor: 4.942

7.  MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.

Authors:  Tao Li; Dong Li; Jianjun Sha; Peng Sun; Yiran Huang
Journal:  Biochem Biophys Res Commun       Date:  2009-03-18       Impact factor: 3.575

8.  Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway.

Authors:  Yan Zhang; Kai-Ji Fan; Qiang Sun; Ai-Zhong Chen; Wen-Long Shen; Zhi-Hu Zhao; Xiao-Fei Zheng; Xiao Yang
Journal:  Nucleic Acids Res       Date:  2012-07-19       Impact factor: 16.971

Review 9.  The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics.

Authors:  J Seidegård; G Ekström
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

10.  MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer.

Authors:  Yongbao Wei; Jinrui Yang; Lu Yi; Yinhuai Wang; Zhitao Dong; Ziting Liu; Shifeng Ou-yang; Hongtao Wu; Zhaohui Zhong; Zhuo Yin; Keqin Zhou; Yunliang Gao; Bin Yan; Zhao Wang
Journal:  Sci Rep       Date:  2014-12-18       Impact factor: 4.379

View more
  7 in total

Review 1.  Ganoderic acid, lanostanoid triterpene: a key player in apoptosis.

Authors:  Balraj Singh Gill; Richa Mehra; Vicky Kumar; Sanjeev Kumar
Journal:  Invest New Drugs       Date:  2017-10-28       Impact factor: 3.850

Review 2.  Vitex negundo and its medicinal value.

Authors:  Balraj Singh Gill; Richa Mehra; Sanjeev Kumar
Journal:  Mol Biol Rep       Date:  2018-10-11       Impact factor: 2.316

3.  Evaluating anti-oxidant potential of ganoderic acid A in STAT 3 pathway in prostate cancer.

Authors:  Balraj Singh Gill; Sanjeev Kumar
Journal:  Mol Biol Rep       Date:  2016-09-17       Impact factor: 2.316

4.  Ganoderic acid targeting multiple receptors in cancer: in silico and in vitro study.

Authors:  Balraj Singh Gill; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2016-09-03

Review 5.  Triterpenes in cancer: significance and their influence.

Authors:  Balraj Singh Gill; Sanjeev Kumar
Journal:  Mol Biol Rep       Date:  2016-06-25       Impact factor: 2.316

6.  Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.

Authors:  A Valentino; A Calarco; A Di Salle; M Finicelli; S Crispi; R A Calogero; F Riccardo; A Sciarra; A Gentilucci; U Galderisi; S Margarucci; G Peluso
Journal:  Oncogene       Date:  2017-07-03       Impact factor: 9.867

Review 7.  Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?

Authors:  Zhongwei Zhao; Carsten Stephan; Sabine Weickmann; Monika Jung; Glen Kristiansen; Klaus Jung
Journal:  Int J Mol Sci       Date:  2017-09-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.